Valeant Pharmaceuticals
16Mar

Valeant Short Sellers Net 343% Profit As Eyes Turn To John Paulson

As Bill Ackman and Pershing Square Capital Management are licking their recent wounds due to well-publicized trades in Herbalife  Ltd. (NYSE:HLF) and Valeant Pharmaceuticals (NYSE:VRX), there are winners as well as losers. As short sellers count their profits, and gradually reduce their exposure, they eye hedge fund manager John Paulson, whose Paulson & Company is still long the stock, for a squeeze opportunity.

Ackman's . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Author

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Related Posts

Russia Pakistan China
01Feb

Beat Artificial Intelligence In Markets By Investing In Individual Stocks?

By

Investor and Forbes contributor John S. Tobey has a rather fatalistic view of artificial intelligence-based investing and trading regimes. In a recent article, the former professional investment manager who formerly... read more

economic growth
26Jun

Barclays Is Buying Value In Anticipation Of Trump Tax Cuts

By

It's once again time to start buying value according to analysts at Barclays as the FANG led S&P 500 rally changes and new leadership arises. The so-called FANG stocks saved... read more

JPMorgan
25Jun

JPM's David Kelly Positive On US Markets, But Points Out Bubbles To Avoid

By

Dr. David Kelly, chief global strategist for JPMorgan Funds, says there are several things the investor should not worry about, things they should worry about and actions that should... read more

13Sep

J D Wetherspoon Set To Brew Up A Storm In Ireland

By

After a failed attempt to enter the Irish market almost a decade ago, Tim Martin and the J D Wetherspoon plc (LON:JDW) (OTCMKTS:JDWPY) pub group are back for another go.... read more

Joel Greenblatt
18Mar

Joel Greenblatt On Finding Value In Stocks

By

Joel Greenblatt CNBC Interview Audio Joel Greenblatt On Finding Value In Stocks Joel Greenblatt, Gotham Asset Management, discusses where he sees opportunity in the markets. read more

Buy Stocks
07Dec

Private Investors Buy Stocks Following Trump's Election

By

Private Investors Buy Stocks Following Trump's Election Individual investors are returning to the markets according to the November American Association of Individual Investors survey. The monthly AAII survey seeks to gauge the... read more

FleetMatics Group
23Sep

Fleetmatics: William Blair’s Rejoinder To The Short Camp

By

On September 19, FleetMatics Group PLC (NYSE:FLTX) fell nearly 16% after the publication of a highly adverse report that alleged, among other things, “accounting shenanigans that inflate profitability, the... read more

Tech Giants 2018
10Oct

Visualizing The World’s Tech Giants 2018

By

Technology companies have a unique advantage over other businesses, and it’s called the network effect. Each new user who joins a platform adds value to everyone already on it.... read more

Jim Grant
27May

If You Want To Make Money, Go To Scary Places: Jim Grant

By

If You Want To Make Money, Go To Scary Places: Jim Grant Published on May 27, 2016 Live from the 2016 Strategic Investment Conference Get the latest updates live from the sold-out... read more

29Apr

Equity investors remain torn

By

The latest results from the weekly surveys on Twitter showed equity investors are still torn between a bullish outlook on the fundamentals vs less than convincing technicals. On the... read more

Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Congrats! Are you a smart person?

We have an exclusive targeted & limited time offer for being a sophisticated and loyal reader.

ValueWalkPremium is a website and newsletter on the latest industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today and get our exclusive content for 40% off. This is our second biggest discount ever!!

Use coupon code VIP20 or click on the button below

Limited time offer only ENDS 2/29/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others

 

0